Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
X4 Announces Publication of Mavorixafor Clinical Data in ‘Blood’
CAMBRIDGE, Mass., Sept. 02, 2020 - X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting dis…
Professional Education Webcasts
Hematopoietic Cell Transplantation as Treatment for Blood Cancers: The Team Approach - For Nurses
For Nurses and Advanced Practice Providers
Kymera Therapeutics Announces Upsized Initial Public Offering
WATERTOWN, Mass., Aug. 20, 2020 - Kymera Therapeutics, Inc. (NASDAQ: KYMR), a biopharmaceutical company focused on discovering and developing novel sm…
Verastem Agrees to Sell Duvelisib Rights to Secura Bio
BOSTON - Aug. 10, 2020 - Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to advancing new medici…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
